TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 43 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 3.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,160 | +27900.0% | 21,169 | +80.0% | 0.00% | – |
| Q1 2023 | $22 | -100.0% | 11,760 | -65.8% | 0.00% | – |
| Q3 2022 | $57,000 | -62.0% | 34,390 | -54.3% | 0.00% | – |
| Q2 2022 | $150,000 | -72.2% | 75,228 | -46.1% | 0.00% | – |
| Q3 2021 | $540,000 | +26.8% | 139,477 | +169.3% | 0.00% | – |
| Q1 2021 | $426,000 | -75.6% | 51,794 | -65.3% | 0.00% | -100.0% |
| Q4 2020 | $1,744,000 | +387.2% | 149,090 | +115.6% | 0.00% | – |
| Q3 2020 | $358,000 | +153.9% | 69,165 | -3.6% | 0.00% | – |
| Q2 2020 | $141,000 | +193.8% | 71,775 | +148.2% | 0.00% | – |
| Q1 2020 | $48,000 | – | 28,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $848,082 | 0.28% |
| Ikarian Capital, LLC | 2,765,530 | $492,265 | 0.06% |
| JOHNSON & JOHNSON | 84,003 | $14,953 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $46,074 | 0.00% |
| BlackRock Inc. | 267,821 | $47,673 | 0.00% |
| Bank of New York Mellon Corp | 10,259 | $1,826 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,835 | $2,819 | 0.00% |
| Truvestments Capital LLC | 318 | $57 | 0.00% |
| Tower Research Capital LLC (TRC) | 10,407 | $1,852 | 0.00% |
| Cutler Group LLC / CA | 1,200 | $0 | 0.00% |